Literature DB >> 2226482

Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage.

C Carbon1.   

Abstract

Determination of tissue levels is widely thought to provide useful information in the investigation of a new antibiotic, however this assumption is not fully justified. In this paper the following questions are covered. Firstly, the methodological problems encountered in the measurement of antibiotic levels in solid tissues and extravascular fluids are described. Secondly, the difficulties encountered in interpreting tissue concentrations are discussed, given the heterogeneity of distribution of drugs, potential intracellular penetration, binding to tissue proteins and local factors reducing antibacterial activity. Thirdly, the respective importance of animal and human data on tissue levels for prediction of efficacy is analysed. In some animal models it is possible to study the conditions affecting antibacterial activity and to obtain data relevant to the clinical situation. However, the inoculum effect, the metabolism of bacteria, the mechanism of the bactericidal action of drugs and the type of infected tissue are important factors to be taken into account. In humans, data obtained from infected tissue is sparse and contributes little to knowledge. Knowledge of tissue levels may be important for establishing whether data obtained in animals can be applied to humans or not. Fourthly, the importance of tissue levels in determining antibiotic dosages is evaluated. In humans, tissue levels are of limited value in the determination of unitary dose and dosage intervals in relation to the clinical response. Trough serum levels of free drug, half-life at the beta-phase and rate of in vitro killing are the most important parameters to be considered. Their relative importance depends mainly on the mode of action of the drug.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226482     DOI: 10.1007/bf01964293

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  40 in total

1.  The relation between plasma and tissue concentrations of antibiotics. Description of a method.

Authors:  H Mattie; J J Hoogeterp; J Hermans
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

2.  Pharmacokinetics of gentamicin in the treatment of renal infection: a therapeutic anomaly explained.

Authors:  T Miller; S Phillips; D North
Journal:  Kidney Int       Date:  1979-02       Impact factor: 10.612

3.  Bacampicillin in acute exacerbations of chronic bronchitis--a dose-range study.

Authors:  F P Maesen; H Beeuwkes; B I Davies; H J Buytendijk; P J Brombacher; J Wessman
Journal:  J Antimicrob Chemother       Date:  1976-09       Impact factor: 5.790

4.  Interstitial diffusion and accumulation of cephalothin according to various modes of intermittent administration to rabbits.

Authors:  C Carbon; N P Chau; A Contrepois; S Lamotte-Barrillon
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

5.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

6.  Gentamicin intravenous infusion rate: effect on interstitial fluid concentration.

Authors:  A J Kozak; D N Gerding; L R Peterson; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

7.  Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

8.  Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.

Authors:  M G Bergeron; S Trottier; C Lessard; D Beauchamp; P M Gagnon
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

9.  Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.

Authors:  J M Decazes; J D Ernst; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  Increased nephrotoxicity of gentamicin in pyelonephritic rats.

Authors:  D Beauchamp; A Poirier; M G Bergeron
Journal:  Kidney Int       Date:  1985-08       Impact factor: 10.612

View more
  5 in total

Review 1.  Clinical role of protein binding of quinolones.

Authors:  Eugénie Bergogne-Bérézin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

3.  Animal models in the evaluation of antimicrobial agents.

Authors:  O Zak; T O'Reilly
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

4.  Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476).

Authors:  E Bernard; M Bensoussan; F Bensoussan; S Etienne; I Cazenave; E Carsenti-Etesse; Y Le Roux; G Montay; P Dellamonica
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

5.  Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model.

Authors:  A Lozniewski; A Duprez; C Renault; F Muhale; M C Conroy; M Weber; A Le Faou; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.